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Understanding the underlying mechanisms in the evolution of new protein functions is key to better directing 
enzyme engineering efforts. Intragenic epistasis (the non-additive interaction of mutations affecting function) is a 
key feature of protein evolution. For example, in TEM-1 ß-lactamase, the mutations E104K and G238S show 
positive epistasis in that their combination show a greater than expected increase in antibiotic resistance1. Here, 
we aim to understand the impact of protein dynamics at slow timescales on epistasis. Large conformational 
rearrangements associated with ligand-binding, turnover of substrate or allostery occur at this timescale2. The 
readily evolvable antibiotic-resistant TEM-1 ß-lactamase and two of its variants that are more dynamic at slow 
timescales serve as models for this study. Our models show similar catalytic activity and substrate recognition, 
thermal stability, as well as conserved motions in fast (ps-ns) and intermediate (ns-s) timescales but different 
motions at slow timescales (s-ms)123. 
 
In this study, we use two different approaches to examine the effect of protein dynamics on epistasis. First, we 
introduced the epistatic mutations E104K and G238S into our dynamic variants. These mutations confer high 
resistance to the antibiotic cefotaxime in TEM-1, increasing catalytic efficiency ~250-fold. The dynamic variants 
present similar kinetic values and increase in catalytic efficiency as does TEM-1 when the epistatic mutations 
are introduced. Molecular dynamic simulations in the presence of cefotaxime support these observations, as the 
presence of the epistatic mutations correlates 
with an increase in catalytically-competent 
conformers. Secondly, we performed directed 
molecular evolution in TEM-1 and its dynamic 
variants towards the hydrolysis of the antibiotic 
cefotaxime.  We examined whether mutational 
pathways accessible to TEM-1 are also 
available in the context of increased dynamics 
at the timescale of turnover.  
Overall, our work highlights that protein 
dynamics at slow timescales does not hinder 
the evolution of new activity in TEM-1 ß-
lactamase engineered variants. Furthermore, 
epistasis can be maintained despite differences 
in dynamics at slow timescales.  
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